(Q37950471)

25 August 2017

title

Olanzapine-fluoxetine combination for the treatment of bipolar depression (English)

1 reference

25 August 2017

1 reference

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

28 October 2011

1 reference

Expert Opinion on Pharmacotherapy

25 August 2017

published in

1 reference

25 August 2017

volume

12

1 reference

25 August 2017

issue

17

1 reference

25 August 2017

page(s)

2751-2758

1 reference

Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Compelling or irrelevant? Using number needed to treat can help decide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

Olanzapine: review of safety 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.632368

10.1517/14656566.2011.632368

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference